Ori acts as Nervomatrix CEO since foundation. With 17 years of experience in the medical device industry serving at various management positions, Ori brings both technical and commercial experience in bringing newly developed products into the market. Ori’s core expertise are multi-disciplinary medical systems architecture and strategic planning & execution of products roll-up from idea, through development and prototype to commercial stage. He has the Vice President for Business Development at APOS-Medical and Sports Technologies Ltd, an Israeli company that developed a unique device and treatment method for rehabilitation of musculoskeletal conditions, and the Chief Technology Officer for a European company that develops, manufactures and markets medical devices for radiation cancer treatment. Earned his MSc in Radiation Physics from the University of London (Graduated with Distinction) and hold a BSc in industrial engineering from the Technion - Israel Institute of Technology.
Zohar is CEO and Managing Partner at NGT VC 2012, a new VC fund, with a 8-year license from the Israeli Government. NGT brings new opportunities, while remaining rooted in Nazareth, the largest Arab city in Israel’s Galilee. NGT start and fund early-stage companies, primarily in innovative medical devices and life sciences, and encourage Arab and Jewish entrepreneurship.
Zohar is former CEO and director of Beta-O2 Technologies (a biomedical company which developed proprietary Implantable bio-artificial pancreas) for a period of 8 years,
Brought the company to one of the world leaders positioning in the area.
Served as CEO of the Technion Entrepreneurial Incubator (TEIC) for a period of 11 years. Led the establishment and investment in more than 40 companies, such as Prolor Biotech (sold to Opko, NYSE: OPK, for $480M on August 2014), Mazor Robotics (NASDAQ: MZOR, TASE: MZOR.TA, www.mazorrobotics.com), ReWalk (NASDAQ: RWLK, www.rewalk.com), Corindus (www.corindus.com), Regentis (www.regentis.co.il), BEE (www.beei.com) and many others.
Gained a wide range of experience in identifying new technologies and in establishing, directing, and creating value for technology-based start-up companies.
Served as a member of the Technion’s Patent Committee. (1998 – 2006).
Earned his M.Sc. in material engineering, a B.Sc. in physics, and a certificate in business management, all from the Technion, Israel Institute of Technology.
Professor. Miguel Gorenberg is the Director of the Nuclear Medicine at Bnai Zion, Poria and Ziv Medical Centers, and Professor at the Faculty of Medicine of the Technion - Israel Institute of Technology. Professor Gorenberg has published over sixty articles, research grants, patents and abstracts.
Kobi acts as Nervomatrix Corp (US, Connecticut based fully owned subsidiary of Nervomatrix Ltd.) CEO and VP Sales at Nervomatrix Ltd.
Kobi is highly experienced executive with 15 years of commercial achievements in pain management.
Kobi is former CEO of Medoc (Medical Device Company which developed and commercialized products and applications for researchers and clinicians at pain centers) for a period of 6 years. Kobi has brought Medoc to grow 600%. Prior to that he help the position of VP Sales & Marketing at Medoc.
Kobi earned his MBA from the University of Texas at Dallas, and holds BA in Sociology and Political Science
Prof Elon Eisenberg is an associate professor of Neurology and Pain Medicine at the faculty of Medicine in the Technion – Israel Institute of Technology and the director of Pain Research Unit at the institute of Pain Medicine, Rambam Healthcare Campus. Professor Eisenberg is a former president of the Israeli Pain Association, and former Director of the Multidisciplinary Pain Relief Unit at Rambam Medical Center in Haifa, Israel His main areas of research are mechanisms and treatment of neuropathic pain including CRPS, cancer pain, opioids and electrical stimulation. Prof. Eisenberg has published nearly 200 articles, book chapters and abstracts on various areas of pain.